[HTML][HTML] Hematopoietic stem cell mobilization strategies to support high-dose chemotherapy: A focus on relapsed/refractory germ cell tumors

E Porfyriou, S Letsa, C Kosmas - World Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
High-dose chemotherapy (HDCT) with autologous hematopoietic stem cell transplantation
has been explored and has played an important role in the management of patients with …

Therapeutic drug monitoring in oncology-What's out there: A bibliometric evaluation on the topic

J Stojanova, JE Carland, B Murnion, V Seah… - Frontiers in …, 2022 - frontiersin.org
Pharmacological therapy is the mainstay of treatment for cancer patients. Despite wide
interpatient variability in systemic drug concentrations for numerous antineoplastics, dosing …

Ototoxicity associated with high‐dose carboplatin for patients with previously treated germ cell tumors

SA Funt, A Knezevic, K Wilson, M Bromberg… - Cancer, 2023 - Wiley Online Library
Background High‐dose carboplatin is an essential part of curative high‐dose chemotherapy
(HDCT) for patients with previously treated germ cell tumors (GCTs). Although hearing loss …

[PDF][PDF] Manuscript NO: 67832 Manuscript Type

E Porfyriou, S Letsa, C Kosmas - researchgate.net
High-dose chemotherapy (HDCT) with autologous hematopoietic stem cell transplantation
has been explored and apparently played an important role in the management of patients …